Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $49,985 |
Sells | 36 | $393,255 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
23 Apr 2024 16:02 | KPTI | Karyopharm Therapeutics Inc | RANGWALA RESHMA | EVP & Chief Medical Officer | 22 Apr 2024 | Sale | 6,789 | 1.17 | 7,943 | D |
05 Apr 2024 17:20 | KPTI | Karyopharm Therapeutics Inc | PAULSON RICHARD A. | President and CEO | 04 Apr 2024 | Sale | 3,563 | 1.29 | 4,596 | D |
06 Mar 2024 16:14 | KPTI | Karyopharm Therapeutics Inc | PAULSON RICHARD A. | President and CEO | 05 Mar 2024 | Sale | 3,573 | 1.3 | 4,645 | D |
04 Mar 2024 19:41 | KPTI | Karyopharm Therapeutics Inc | RANGWALA RESHMA | EVP & Chief Medical Officer | 01 Mar 2024 | Sale | 5,969 | 1.2 | 7,163 | D |
04 Mar 2024 19:41 | KPTI | Karyopharm Therapeutics Inc | RANGWALA RESHMA | EVP & Chief Medical Officer | 29 Feb 2024 | Sale | 15,667 | 1.17 | 18,330 | D |
04 Mar 2024 19:40 | KPTI | Karyopharm Therapeutics Inc | POULTON STUART | EVP, Chief Development Officer | 01 Mar 2024 | Sale | 6,155 | 1.2 | 7,386 | D |
04 Mar 2024 19:40 | KPTI | Karyopharm Therapeutics Inc | POULTON STUART | EVP, Chief Development Officer | 29 Feb 2024 | Sale | 16,311 | 1.17 | 19,084 | D |
04 Mar 2024 19:39 | KPTI | Karyopharm Therapeutics Inc | MASON MICHAEL | EVP, CFO & Treasurer | 01 Mar 2024 | Sale | 6,162 | 1.2 | 7,394 | D |
04 Mar 2024 19:39 | KPTI | Karyopharm Therapeutics Inc | MASON MICHAEL | EVP, CFO & Treasurer | 29 Feb 2024 | Sale | 27,687 | 1.17 | 32,394 | D |
04 Mar 2024 19:38 | KPTI | Karyopharm Therapeutics Inc | MANO MICHAEL | SVP, General Counsel&Secretary | 01 Mar 2024 | Sale | 3,576 | 1.2 | 4,291 | D |
04 Mar 2024 19:38 | KPTI | Karyopharm Therapeutics Inc | MANO MICHAEL | SVP, General Counsel&Secretary | 29 Feb 2024 | Sale | 16,973 | 1.17 | 19,858 | D |
04 Mar 2024 19:37 | KPTI | Karyopharm Therapeutics Inc | CHENG SOHANYA ROSHAN | EVP & Chief Commercial Officer | 01 Mar 2024 | Sale | 5,109 | 1.2 | 6,131 | D |
04 Mar 2024 19:37 | KPTI | Karyopharm Therapeutics Inc | CHENG SOHANYA ROSHAN | EVP & Chief Commercial Officer | 29 Feb 2024 | Sale | 21,840 | 1.17 | 25,553 | D |
04 Mar 2024 19:36 | KPTI | Karyopharm Therapeutics Inc | PAULSON RICHARD A. | President and CEO | 01 Mar 2024 | Sale | 19,374 | 1.2 | 23,249 | D |
04 Mar 2024 19:36 | KPTI | Karyopharm Therapeutics Inc | PAULSON RICHARD A. | President and CEO | 29 Feb 2024 | Sale | 80,470 | 1.17 | 94,150 | D |
29 Feb 2024 17:35 | KPTI | Karyopharm Therapeutics Inc | MASON MICHAEL | EVP, CFO & Treasurer | 27 Feb 2024 | Sale | 2,545 | 1.3238 | 3,369 | D |
20 Feb 2024 16:59 | KPTI | Karyopharm Therapeutics Inc | POULTON STUART | EVP, Chief Development Officer | 15 Feb 2024 | Sale | 99 | 1.4 | 139 | D |
20 Feb 2024 16:59 | KPTI | Karyopharm Therapeutics Inc | POULTON STUART | EVP, Chief Development Officer | 15 Feb 2024 | Sale | 5,748 | 1.33 | 7,645 | D |
08 Feb 2024 16:36 | KPTI | Karyopharm Therapeutics Inc | MASON MICHAEL | EVP, CFO & Treasurer | 06 Feb 2024 | Sale | 4,205 | 1.5865 | 6,671 | D |
08 Feb 2024 16:34 | KPTI | Karyopharm Therapeutics Inc | PAULSON RICHARD A. | President and CEO | 06 Feb 2024 | Sale | 4,012 | 1.5865 | 6,365 | D |
08 Jan 2024 21:00 | KPTI | Karyopharm Therapeutics Inc | PAULSON RICHARD A. | President and CEO | 04 Jan 2024 | Sale | 4,114 | 0.82 | 3,373 | D |
05 Dec 2023 17:03 | KPTI | Karyopharm Therapeutics Inc | PAULSON RICHARD A. | President and CEO | 04 Dec 2023 | Sale | 3,622 | 0.79 | 2,861 | D |
07 Nov 2023 17:32 | KPTI | Karyopharm Therapeutics Inc | PAULSON RICHARD A. | President and CEO | 06 Nov 2023 | Sale | 3,606 | 0.9203 | 3,319 | D |
05 Oct 2023 16:46 | KPTI | Karyopharm Therapeutics Inc | PAULSON RICHARD A. | President and CEO | 04 Oct 2023 | Sale | 3,589 | 1.27 | 4,558 | D |
12 Sep 2023 16:07 | KPTI | Karyopharm Therapeutics Inc | BOHLIN GAREN G | Director | 12 Sep 2023 | Purchase | 41,140 | 1.215 | 49,985 | D |
06 Sep 2023 16:06 | KPTI | Karyopharm Therapeutics Inc | PAULSON RICHARD A. | President and CEO | 05 Sep 2023 | Sale | 64 | 1.32 | 84 | D |
06 Sep 2023 16:06 | KPTI | Karyopharm Therapeutics Inc | PAULSON RICHARD A. | President and CEO | 05 Sep 2023 | Sale | 3,558 | 1.33 | 4,732 | D |
05 Sep 2023 16:30 | KPTI | Karyopharm Therapeutics Inc | MASON MICHAEL | EVP, CFO & Treasurer | 01 Sep 2023 | Sale | 6,913 | 1.3313 | 9,203 | D |
05 Sep 2023 16:29 | KPTI | Karyopharm Therapeutics Inc | MANO MICHAEL | SVP, General Counsel&Secretary | 01 Sep 2023 | Sale | 3,888 | 1.3313 | 5,176 | D |
05 Sep 2023 16:27 | KPTI | Karyopharm Therapeutics Inc | CHENG SOHANYA ROSHAN | EVP & Chief Commercial Officer | 01 Sep 2023 | Sale | 7,415 | 1.3313 | 9,872 | D |
08 Aug 2023 17:02 | KPTI | Karyopharm Therapeutics Inc | PAULSON RICHARD A. | President and CEO | 07 Aug 2023 | Sale | 3,722 | 1.72 | 6,402 | D |
01 Aug 2023 17:37 | KPTI | Karyopharm Therapeutics Inc | POULTON STUART | EVP, Chief Development Officer | 28 Jul 2023 | Sale | 2,845 | 1.7 | 4,836 | D |
06 Jul 2023 17:36 | KPTI | Karyopharm Therapeutics Inc | PAULSON RICHARD A. | President and CEO | 05 Jul 2023 | Sale | 3,538 | 1.72 | 6,085 | D |
12 Jun 2023 16:07 | KPTI | Karyopharm Therapeutics Inc | CHENG SOHANYA ROSHAN | EVP & Chief Commercial Officer | 08 Jun 2023 | Sale | 1,839 | 2.35 | 4,322 | D |
07 Jun 2023 16:11 | KPTI | Karyopharm Therapeutics Inc | PAULSON RICHARD A. | President and CEO | 05 Jun 2023 | Sale | 3,536 | 2.2404 | 7,922 | D |
05 Jun 2023 16:10 | KPTI | Karyopharm Therapeutics Inc | MASON MICHAEL | EVP, CFO & Treasurer | 02 Jun 2023 | Sale | 631 | 2.22 | 1,401 | D |
05 May 2023 17:06 | KPTI | Karyopharm Therapeutics Inc | PAULSON RICHARD A. | President and CEO | 04 May 2023 | Sale | 3,805 | 3.3516 | 12,753 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)